This Medication May Kill You: Cognitive Overload and Forced Commercial Speech
Keywords
Bioethics and Medical EthicsBusiness Law, Public Responsibility, and Ethics
Ethics and Political Philosophy
Ethics in Religion
Legal Ethics and Professional Responsibility
Full record
Show full item recordOnline Access
https://scholarworks.wmich.edu/ethics_papers/105https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=1099&context=ethics_papers
Abstract
The Federal Government requires pharmaceutical manufacturers to provide prospective customers with an extraordinary amount of information. Justified under the doctrine of informed consent, the Food and Drug Administration has imposed comprehensive guidelines that regulate virtually every aspect of how medications can be marketed. Similar obligations are imposed on physicians involved in biomedical research. Although informed consent is a cornerstone to the ethical practice of medicine, recent studies employing fMRI technology suggest that mandated disclosure of “too much” information can result in cognitive overload and irrational decision making. The paradoxical effect of the mandated disclosure requirements is that they likely lead to patients choosing to not take beneficial medications. This paradoxical effect arises from three well-studied psychological phenomena: (1) “Recency-Primacy, (2) “Satisficing” and “Probability Neglect.” The combination of these three effects in patients who have been inundated with excessive information results in decision making based on anecdote and emotion, instead of logic. Studies also suggest that most people are extraordinarily bad in assessing risk, particularly when an activity poses an infinitesimal but highly consequential risk. In plain language, people overreact to miniscule risk. Hence, when the government requires pharmaceutical manufacturers to disclose in advertisements such risks, the effect is for patients to err on the wrong side; i.e. not taking medication that could provide great benefit. Government-mandated messages also raise serious First Amendment concerns. Government action that compels physicians and pharmaceutical companies to convey mandated messages sits at the crossroads of two divergent legal doctrines. Compelled speech of “political” messages are strongly disfavored under the First Amendment. Regulation of commercial speech, however, is generally subject to a lower level of scrutiny. These two doctrines, one focused on laws compelling speech and the other on laws which restrict speech, conflict in situations where the government imposes informed consent requirements which are contrary to the speaker’s favored message. This multidisciplinary study combines case law, the philosophical underpinnings of the First Amendment, political theory, and emerging research into how the brain organizes and manages information to come to the conclusion that many of the rules imposed by the government to insure informed consent are counterproductive and likely unconstitutional. This presentation is adopted from an article previously published by the authors in the Whittier Law Review entitled “This Medication may Kill You: Cognitive Overload and Forced Commercial Speech,” 35 Whittier Law Review 1.Date
2016-03-18Type
textIdentifier
oai:scholarworks.wmich.edu:ethics_papers-1099https://scholarworks.wmich.edu/ethics_papers/105
https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=1099&context=ethics_papers
Related items
Showing items related by title, author, creator and subject.
-
Mitteilungen der Vereinigung Österreichischer Bibliothekarinnen und BibliothekareFerus, A. (Andreas) (Vereinigung Österreichischer Bibliothekarinnen und Bibliothekare, 2014-03)Heft 1 des 67. Jahrgangs (2014) der Mitteilungen der Vereinigung Österreichischer Bibliothekarinnen und Bibliothekare
-
Ethical Issues in the Big Data IndustryMartin, Kirsten E (AIS Electronic Library (AISeL), 2015-05-28)Big Data combines information from diverse sources to create knowledge, make better predictions and tailor services. This article analyzes Big Data as an industry, not a technology, and identifies the ethical issues it faces. These issues arise from reselling consumers' data to the secondary market for Big Data. Remedies for the issues are proposed, with the goal of fostering a sustainable Big Data Industry.Click here for podcast summary (mp3)Click here for free 2-page executive summary (pdf)Click here for free presentation slides (pptx)
-
But What IS the 'Right Thing'?: Ethics and Information Systems in the Corporate DomainSmith, H. Jeff (AIS Electronic Library (AISeL), 2008-02-08)Information systems executives, and other executives, are often prodded to "do the right thing" when they face ethical quandaries. But how do they determine what is "right" ethically, especially when the ethical quandaries occur in the corporate domain? Some individuals rely solely on their own emotions, but they often have a hard time convincing rational thinkers to embrace their position. Other individuals rely on traditional philosophical theories, but this approach is seldom optimal in the corporate domain because the traditional philosophical theories do not specifically address the corporate setting. However, two theories do address ethical quandaries in the private sector: stockholder theory and stakeholder theory. This article discusses these two theories. Stockholder theory holds that executives should resolve ethical quandaries by taking actions that maximize the long-term profits to stockholders without violating the law or engaging in fraud or deception. Stakeholder theory claims that executives should resolve ethical quandaries by balancing stakeholder interests without violating the rights of any stakeholder. These theories are explored by first applying them to a specific real-world quandary: Blockbuster Video's reported plans to market its customer lists. Then the theories are applied to several other current quandaries. Finally, the article explores action steps for applying each theory.